Literature DB >> 8282966

Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease.

N Takasu1, N Ohara, T Yamada, I Komiya.   

Abstract

Although the factors that cause developments or exacerbations of autoimmune thyroid dysfunction are not known, the changes of glucocorticoids might modulate the autoimmune responses. We compared the postoperative changes in thyroid function in one patient with Carney's complex with primary adrenocortical nodular dysplasia (PAND) and 19 patients with Cushing's disease due to ACTH-producing pituitary adenoma. Thyroid dysfunction developed after surgery for glucocorticoid excess in two patients; one with Carney's complex had transient hypothyroidism after bilateral adrenalectomy for PAND, and the other had transient hyperthyroidism due to thyroiditis after removal of ACTH-producing pituitary adenoma for Cushing's disease. Both patients had no thyroid autoantibodies at the time of surgery. None of the remaining 18 patients had clinically evident thyroid disease or increased antithyroidantibody titers. Development of autoimmune thyroid dysfunction may be observed after surgery for glucocorticoid excess in the patients with any forms of Cushing's syndrome, even who do not have thyroid antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282966     DOI: 10.1007/BF03348914

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Immunoendocrine interactions and autoimmunity.

Authors:  A M McGregor
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

2.  A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.

Authors:  S Monno; N Takasu
Journal:  Endocrinol Jpn       Date:  1989-04

3.  The complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; H Gordon; P C Carpenter; B V Shenoy; V L Go
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

4.  Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma.

Authors:  N Takasu; I Komiya; Y Nagasawa; T Asawa; T Yamada
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

5.  Thyrotoxicosis with painless thyroiditis.

Authors:  P D Woolf; R Daly
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

6.  Thyrotoxicosis due to "silent" thyroiditis.

Authors:  P D Papapetrou; I M Jackson
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

7.  Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.

Authors:  N Takasu; T Yamada; M Katakura; K Yamauchi; Y Shimizu; Y Ishizuki
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

  7 in total
  4 in total

1.  Autoimmune thyroid disease after successful treatment of Cushing's syndrome.

Authors:  P Colombo; E Passini; T Re; B Ambrosi
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

2.  A Patient with Postpartum Hypopituitarism (Sheehan's Syndrome) Developed Postpartum Autoimmune Thyroiditis (Transient Thyrotoxicosis and Hypothyroidism): A Case Report and Review of the Literature.

Authors:  Nobuyuki Takasu; Yoshirou Nakayama
Journal:  J Thyroid Res       Date:  2011-04-11

3.  Management of thyrotoxicosis occurring after surgery for Cushing's disease: a case series.

Authors:  Shenzhong Jiang; Chengxian Yang; Ming Feng; Yong Yao; Kan Deng; Bing Xing; Lin Lu; Huijuan Zhu; Renzhi Wang; Xinjie Bao
Journal:  Gland Surg       Date:  2021-05

4.  Graves' Disease after Adrenalectomy for Cushing's Syndrome.

Authors:  Yuji Hiromatsu; Hiroyuki Eguchi; Yui Nakamura; Kei Mukohara
Journal:  Intern Med       Date:  2020-09-05       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.